Evidence map›Paper›PMID 29907869›Full record

ArticleMucosal immunology2018

BVES is required for maintenance of colonic epithelial integrity in experimental colitis by modifying intestinal permeability.

Yash A Choksi, Vishruth K Reddy, Kshipra Singh, Caitlyn W Barrett, Sarah P Short, Bobak Parang, Cody E Keating, Joshua J Thompson, Thomas G Verriere, Rachel E Brown and 9 more

Abstract read
In one paragraph

Article in Mucosal immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. LncRNACentral-European journal of immunology · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Transition from Gastric Intestinal Metaplasia to Gastric Cancer InvolvesInternational journal of molecular sciences · 2021
    Article
  10. Review
  11. Review
  12. A Novel Postbiotic FromFrontiers in microbiology · 2019
    Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 2 countries.

Yash A ChoksiDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Vishruth K ReddyDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Kshipra SinghDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Caitlyn W BarrettDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Sarah P ShortDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Bobak ParangDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Cody E KeatingDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Joshua J ThompsonDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Thomas G VerriereDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Rachel E BrownDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
M Blanca PiazueloDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
David M BaderDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
M Kay WashingtonDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Mukul K MittalDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Thomas BrandDevelopmental Dynamics, Heart Science Centre, Imperial College London, London, UK.
Alain P GobertDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Lori A CoburnDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Keith T WilsonDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Christopher S WilliamsDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. christopher.s.williams@vanderbilt.edu.
Vanderbilt University · USVanderbilt University Medical Center · USImperial College London · GBVA Tennessee Valley Healthcare System · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Understanding and Controlling p120 Dysfunction in CRCP50CA095103 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI COFFEY, ROBERT J. · 2002 to 2017
$33.6M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
TRANSGENIC MOUSE/ ES CELL SHARES RESOURCESP60DK020593 · NIDDK · VANDERBILT UNIVERSITY · PI MCGUINNESS, OWEN P · 1986 to 2011
$28.1M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007347 · NIGMS · VANDERBILT UNIVERSITY · PI WILLIAMS, CHRISTOPHER S. · 1985 to 2023
$26.3M
Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal CancerP50CA236733 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI STEPHEN W. FESIK · 2019 to 2026
$19.6M
Shop Module CoreP30EY008126 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Kevin L Schey · 1989 to 2026
$19.6M
Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2001 to 2015
$14.9M
TRAINING IN GASTROENTEROLOGYT32DK007673 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 1992 to 2026
$8.4M
BLRD VA I01 BX001426BLRD VA I01 BX001453BLRD VA IK2 BX002126British Heart Foundation PG/14/83/31128Medical Research Council MR/J010383/1NCATS NIH HHS UL1 TR000445NCATS NIH HHS UL1 TR002243NCCIH NIH HHS R01 AT004821NCI NIH HHS F31 CA167920NCI NIH HHS P30 CA068485NCI NIH HHS P50 CA095103NCI NIH HHS P50 CA236733NEI NIH HHS P30 EY008126NIDDK NIH HHS F30 DK096718NIDDK NIH HHS F30 DK103498NIDDK NIH HHS F32 DK108492NIDDK NIH HHS K08 DK080221NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P30 DK058404NIDDK NIH HHS R01 DK099204NIDDK NIH HHS T32 DK007673NIDDK NIH HHS U24 DK059637NIDDK NIH HHS U2C DK059637NIGMS NIH HHS T32 GM007347NIH HHS S10 OD021630
6 · The paper itself

Abstract

Blood vessel epicardial substance (BVES), or POPDC1, is a tight junction-associated transmembrane protein that modulates epithelial-to-mesenchymal transition (EMT) via junctional signaling pathways. There have been no in vivo studies investigating the role of BVES in colitis. We hypothesized that BVES is critical for maintaining colonic epithelial integrity. At baseline, Bves

Indexed as

AdultAnimalsCaco-2 CellsCell Adhesion MoleculesCell LineCell Line, TumorCitrobacter rodentiumCoculture TechniquesColitis, UlcerativeColonDextran SulfateEpithelial CellsEscherichia coliFemaleHEK293 CellsHumansCell Adhesion MoleculesDextran SulfateMembrane ProteinsMuscle ProteinsPOPDC1 protein, humanRNA, Messenger

Identifiers

PMID29907869
PMCPMC6162166
OpenAlexW2807902016

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.